TIMCEVIBART
UNII P45RTW33K4

Substance Identification & Data

This profile provides standardized clinical and technical data for Timcevibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P45RTW33K4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2857862-27-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
P45RTW33K4
CAS Registry Number
2857862-27-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TIMCEVIBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C203087
National Cancer Institute reference terminology for clinical and research data.
INN ID
12929
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Timcevibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TIMCEVIBART

Common Names & Synonyms

GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-445) (VH (HOMO SAPIENS IGHV3-66*01 (96.9%) -(IGHD) -IGHJ3*02 (100%), CDR-IMGT (8.7.10) (26-33.51-57.96-105)) (1-116) -HOMO SAPIENS IGHG1*01, G1M17,1 CH1 K120, CH3 D12, L14, G1V50-79 CH2 DELE1.4, P1.3, V1.2, A1.A, G27, Q110, S115 (CH1 K120 (213) (117-214), HINGE 1-15 (215-229), CH2 E1.4>DEL, L1.3>P (232), L1.2>V (233), G1.1>A (234), D27>G (263), A110>Q (325), A115>S (328) (230-338), CH3 D12 (354), L14 (356) (339-443), CHS (444-445)) (117-445)), (219-215')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-215') (V-KAPPA (HOMO SAPIENS IGKV1-9*01 (97.9%) -IGKJ3*01 (100%), CDR-IMGT (6.3.10) (27'-32'.50'-52'.89'-98')) (1'-108') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (154'), V101 (192') (109'-215')); DIMER (225-225'':228-228'')-BISDISULFIDE,
IMMUNOGLOBULIN G1 (232-PROLINE,233-VALINE,234-ALANINE,263-GLYCINE,325-GLUTAMINE,328-SERINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN S1 RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL COR-101 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL COR-101 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) PROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY
TIMCEVIBART [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus